Risk of thromboembolism in patients with metastatic renal cell carcinoma treated with combination‐based immunotherapy
British Journal of Haematology · 2026-07 · 209 (1) · 366-370
DOI: 10.1111/bjh.70526 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 03.05.2026. Verfasst von Yu-Cheng Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA.
- Division of Pulmonary, Critical Care and Sleep Medicine, University at Buffalo, Buffalo, New York, USA.
- Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Medicine, Northwell Health Cancer Institute, New York, USA.
ORCID-Profile: Yu-Cheng Chang
Zitieren
APA
Chang, Y. C., Lin, H. K., Piwowarski, J., Lee, Y. C., Peng, C. Y., Gao, W., & Chiang, C. H. (2026). Risk of thromboembolism in patients with metastatic renal cell carcinoma treated with combination‐based immunotherapy. British Journal of Haematology, 209(1), 366-370. https://doi.org/10.1111/bjh.70526
Vancouver
Chang YC, Lin HK, Piwowarski J, Lee YC, Peng CY, Gao W, et al. Risk of thromboembolism in patients with metastatic renal cell carcinoma treated with combination‐based immunotherapy. British Journal of Haematology. 2026;209(1):366-370. doi:10.1111/bjh.70526
BibTeX
@article{Chang2026,
author = {Chang, Yu-Cheng and Lin, Hao-Kuen and Piwowarski, Joseph and Lee, Yu-Che and Peng, Chun-Yu and Gao, Wenli and Chiang, Cho-Han},
title = {Risk of thromboembolism in patients with metastatic renal cell carcinoma treated with combination‐based immunotherapy},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {1},
pages = {366--370},
doi = {10.1111/bjh.70526}
}
EUVIMED